Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sílvia Paula-Gomes"'
Autor:
Isabela Jesus de Deus, Ana Flávia Martins-Silva, Miliane Martins de Andrade Fagundes, Sílvia Paula-Gomes, Fernanda Guimarães Drummond e Silva, Larissa Leandro da Cruz, Aline Rezende Ribeiro de Abreu, Karina Barbosa de Queiroz
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
NLRP3 inflammasome has a key role in chronic low-grade metabolic inflammation, and its excessive activation may contribute to the beginning and progression of several diseases, including hepatic insulin resistance (hIR). Thus, this review aims to hig
Externí odkaz:
https://doaj.org/article/1937965c51134de3a7ad27d1382ab95b
Autor:
Natalia Lautherbach, Dawit A.P. Gonçalves, Wilian A. Silveira, Sílvia Paula-Gomes, Rafael Rossi Valentim, Neusa M. Zanon, Marcelo G. Pereira, Elen H. Miyabara, Luiz C.C. Navegantes, Isis C. Kettelhut
Publikováno v:
Molecular Metabolism, Vol 60, Iss , Pp 101492- (2022)
Objective: Although it is well established that urocortin 2 (Ucn2), a peptide member of the corticotrophin releasing factor (CRF) family, and its specific corticotrophin-releasing factor 2 receptor (CRF2R) are highly expressed in skeletal muscle, the
Externí odkaz:
https://doaj.org/article/8fb5755fb87d45968e670b90f0f6b511
Autor:
Jérôme Roy, Alexandre Lucas, Marion Laudette, Bijan Ghaleh, Olivier Lairez, Florence Tortosa, Caroline Conte, Yannis Sainte-Marie, Pierre Sicard, Malik Bisserier, Frank Lezoualc'h, Sandrine Pons, Sílvia Paula-Gomes, Loubina Fazal, Jeanne Mialet-Perez, Jérémy Fauconnier
Publikováno v:
Circulation Research
Circulation Research, American Heart Association, 2017, 120 (4), pp.645-657. ⟨10.1161/CIRCRESAHA.116.309859⟩
Circulation Research, 2017, 120 (4), pp.645-657. ⟨10.1161/CIRCRESAHA.116.309859⟩
Circulation Research, American Heart Association, 2017, 120 (4), pp.645-657. ⟨10.1161/CIRCRESAHA.116.309859⟩
Circulation Research, 2017, 120 (4), pp.645-657. ⟨10.1161/CIRCRESAHA.116.309859⟩
Rationale: Although the second messenger cyclic AMP (cAMP) is physiologically beneficial in the heart, it largely contributes to cardiac disease progression when dysregulated. Current evidence suggests that cAMP is produced within mitochondria. Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31a152c647645a1ee9a4d2d23d666dc6
https://hal.inrae.fr/hal-03236846
https://hal.inrae.fr/hal-03236846